SOX2 Regulates YAP1 to Maintain Stemness and Determine Cell Fate in the Osteo-Adipo Lineage  by Seo, Eunjeong et al.
Cell Reports
ArticleSOX2 Regulates YAP1
to Maintain Stemness and Determine Cell Fate
in the Osteo-Adipo Lineage
Eunjeong Seo,2,5 Upal Basu-Roy,1,5 Preethi H. Gunaratne,3 Cristian Coarfa,4 Dae-Sik Lim,2,* Claudio Basilico,1
and Alka Mansukhani1,*
1Department of Microbiology, New York University School of Medicine, New York, NY 10016, USA
2National Creative Initiatives Center for Cell Division and Differentiation, Department of Biological Sciences, Korea Advanced Institute of
Science and Technology (KAIST), 373-1 Guseoung-D, Yuseong-G, Daejeon 305-701, Korea
3Department of Biology and Biochemistry, University of Houston, Houston, TX 77204, USA
4Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA
5These authors contributed equally to this work
*Correspondence: daesiklim@kaist.ac.kr (D.-S.L.), alka.mansukhani@med.nyu.edu (A.M.)
http://dx.doi.org/10.1016/j.celrep.2013.05.029SUMMARY
The osteoblastic and adipocytic lineages arise from
mesenchymal stem cells (MSCs), but few regulators
of self-renewal and early cell-fate decisions are
known. Here, we show that the Hippo pathway
effector YAP1 is a direct target of SOX2 and can
compensate for the self-renewal defect caused by
SOX2 inactivation in osteoprogenitors and MSCs.
Osteogenesis is blocked by high SOX2 or YAP1,
accelerated by depletion of either one, and the inhibi-
tion of osteogenesis by SOX2 requires YAP1. SOX2
favors adipogenesis and induces PPARg, but adipo-
genesis can only occur withmoderate levels of YAP1.
YAP1 induction by SOX2 is restrained in adipogene-
sis, and both YAP1 overexpression and depletion
inhibit the process. YAP1 binds b-catenin and
directly induces the Wnt antagonist Dkk1 to dampen
pro-osteogenic Wnt signals. We demonstrate a
Hippo-independent regulation of YAP1 by SOX2
that cooperatively antagonizes Wnt/b-catenin sig-
nals and regulates PPARg to determine osteogenic
or adipocytic fates.
INTRODUCTION
Bone- and fat-forming cells are both derived from adult multi-
potent progenitor cells that are often referred to as mesen-
chymal stem cells (MSCs) or mesenchymal progenitor cells
(MPCs). Bone marrow (BM)-derived MSCs (BM-MSCs) in cul-
ture have the capacity to self-renew as well as to form differ-
entiated cell types of the mesenchymal lineage, such as
osteoblasts, adipocytes, chondrocytes, and myoblasts (Ca-
plan, 1991; Pittenger et al., 1999). Although key transcription
factors that specify the different lineages are known, the regu-
lation of self-renewal and cell-fate choice in MSCs and more
restricted progenitor cells is not well understood. SeveralCstudies have suggested that the osteoblastic and adipocytic
lineages are alternate fates, and increased adipogenesis corre-
lates with decreased osteogenesis during development and
aging (Takada et al., 2009; Urs et al., 2010; Verma et al.,
2002). The transcription factor SOX2 is required to maintain
self-renewal and the undifferentiated state in the osteoblastic
lineage and MSCs (Basu-Roy et al., 2010; Park et al.,
2012b). SOX2 expression is downregulated upon osteoblastic
differentiation, and its constitutive expression prevents osteo-
blastic differentiation by inducing stemness-related genes
and inhibiting the Wnt pathway (Holmes et al., 2011; Mansu-
khani et al., 2005; Park et al., 2012b; Seo et al., 2011), which
is pro-osteogenic and inhibits the adipogenic fate (Kang et al.,
2007; Prestwich and Macdougald, 2007). SOX2 can bind
b-catenin, a key mediator of canonical Wnt signaling, and
directly induce expression of the negative regulators APC
and GSK3b, which promote b-catenin degradation (Mansu-
khani et al., 2005; Seo et al., 2011).
SOX2 is a member of the HMG-domain family and is a
pluripotency transcription factor that is required to maintain
the stemness and self-renewal of embryonic stem cells
(ESCs) (Niwa, 2007). It is now evident that SOX2 is required
for the homeostasis of several tissues through the maintenance
of adult stem cells (Arnold et al., 2011). SOX2 expression is also
seen in several undifferentiated cancers, including osteosar-
comas (Bass et al., 2009; Basu-Roy et al., 2011; Riggi et al.,
2010).
Yes-associated protein 1 (YAP1) is a key downstream effector
of the Hippo signaling pathway that controls cell proliferation and
organ size (Halder and Johnson, 2011; Pan, 2010; Sudol, 1994;
Zhao et al., 2010). YAP1 is a transcriptional coactivator
that maintains the pluripotency of ESCs, where it acts as a
coactivator of the TEAD transcription factors to regulate several
stemness genes (Lian et al., 2010). The transcriptional activity of
YAP1 is restrained by phosphorylation via the Hippo (MST/LATS)
pathway, a major growth- and tumor-suppressive pathway that
is activated by increased cell density and thought to be a medi-
ator of contact inhibition (Zeng and Hong, 2008; Zhao et al.,
2007, 2011). When the Hippo pathway is active, YAP1 and itsell Reports 3, 2075–2087, June 27, 2013 ª2013 The Authors 2075
paralog, TAZ (WWTR1), are phosphorylated and sequestered in
the cytoplasm, which inhibits their transcriptional activity (Pan,
2007; Zhao et al., 2011). Inactivation of the Hippo pathway leads
to increases in the nuclear localization and TEAD-mediated tran-
scriptional activity of YAP1 and TAZ (Ota and Sasaki, 2008; Zhao
et al., 2007). TAZ was identified as a fate-determination factor
that binds to and activates Runx2, a transcriptional regulator of
the osteoblast lineage, while concurrently binding to and inacti-
vating PPARg, the master regulator of adipogenesis (Hong et al.,
2005). Although YAP1 and TAZ are often considered functionally
analogous orthologs of Drosophila Yorkie (Yki), here we report
that in the osteo-adipo lineage, YAP1’s functions are distinct
from those of TAZ.
We demonstrate that YAP1 is a direct transcriptional target of
SOX2 in osteoprogenitors and MSCs where SOX2 function is
required for self-renewal. Constitutive expression of YAP1 can
rescue the lethality caused by SOX2 depletion and restores
self-renewal and proliferative capacity. Depletion of either
SOX2 or YAP1 enables osteogenesis and prevents adipogenic
differentiation. SOX2 favors adipogenesis, which requires phys-
iological levels of YAP1 expression. The SOX2-YAP1 axis is
required for blocking osteogenesis, but during adipogenesis,
where YAP1 expression is restrained, SOX2 overexpression
can compensate for depletion of YAP1. The effect of YAP1 is
mostly due to its nuclear transcriptional function because it is
mimicked by a transcriptionally active YAP1 mutant or knock-
down of hippo pathway components (MST1/2) that restrain
nuclear YAP1 transcriptional activity. We show that, like SOX2,
YAP1 inhibits Wnt signaling and the depletion of YAP1 induces
Wnt signaling. YAP1 binds b-catenin and induces Dkk1, a nega-
tive regulator ofWnt signaling, tomaintain stemness and prevent
osteogenesis.
Our studies identify a functional relation between SOX2 and
the Hippo signaling pathway, and indicate that SOX2 and
YAP1 act cooperatively as a control switch to regulate self-
renewal and mesenchymal cell lineage choice.
RESULTS
Yap1 Is Transcriptionally Regulated by SOX2
SOX2 is required for the self-renewal of osteoprogenitors and
affects the expression of numerous genes involved in prolifera-
tion, stemness, and intracellular signaling, as revealed by
gene-expression analysis of cells in which SOX2 was deleted
by CRE virus-mediated excision (Basu-Roy et al., 2010; Seo
et al., 2011). To investigate genes directly bound and regulated
by SOX2 in osteoprogenitor cells, we performed SOX2 chro-
matin immunoprecipitation sequencing (ChIP-seq) analysis
using both wild-type (WT) osteoprogenitor cells (OBI) and the
same cells transduced to express higher amounts (by 5- to
6-fold) of SOX2 (OB1-SOX2). From the overlay of microarray
and ChIP-seq data, we found that one of the direct SOX2-
regulated targets was YAP1. ChIP-seq analysis showed two
‘‘peaks’’ of SOX2 binding in the Yap1 gene, the first near
exon I, overlapping a CpG island, and the second on exon II (Fig-
ure 1A). The peaks were detected inWT as well as in SOX2-over-
expressing cells, and spanned SOX2 consensus binding sites
(red bars in the schematic in Fig. 1B). ChIP-PCR assays further2076 Cell Reports 3, 2075–2087, June 27, 2013 ª2013 The Authorsconfirmed that SOX2-binding genomic fragments of the Yap1
gene were enriched in SOX2-overexpressing cells (Figure 1B).
We previously described the gene-expression changes in
osteoprogenitor cells derived from mice bearing the SOX2
floxed (F) gene (SOX2F/F or SOX2F/) after in vitro infection
with a CRE virus (Seo et al., 2011). SOX2 depletion by CRE-
expressing lentivirus in SOX2F/F cells led to reduced expression
of YAP1 but not of its paralog, TAZ (Figure 1C). Consistently,
overexpression of SOX2 resulted in increased YAP1 expression
not only in osteoprogenitors (Figure 1D) but also in MSCs and
C3H10T1/2 cells, which serve as a model of multipotent mesen-
chymal cells (Figure S1A). Using a fibroblast growth factor 4
(FGF4) minimal promoter-driven Venus (enhanced GFP
[EGFP]) or firefly luciferase reporter plasmid, we determined
whether a 243 bp Yap1 genomic region including the SOX2
binding sites near the first exon could be activated by SOX2.
In 293T cells, SOX2 expression induced Venus expression
driven by the YAP1 50 243 bp region (Figure 1E), and the lucif-
erase activity of a construct with the same genomic region
was increased by SOX2 in C3H10T1/2 cells (Figure 1F). Muta-
genesis of the SOX2-binding elements in the 243 bp region
confirmed that the induction was dependent on SOX2 binding
(Figure S1B). These results indicate that YAP1 is a direct down-
stream target of SOX2.
YAP1 Expression Is Regulated by SOX2 In Vivo and
In Vitro
We showed that an osteoblast-specific conditional knockout
(CKO) of SOX2 led to a low-bone-density phenotype, and dele-
tion of SOX2 in osteoprogenitor cells caused cell senescence,
revealing that SOX2 is important for maintaining osteoprogeni-
tors and for bone formation (Basu-Roy et al., 2010). We deter-
mined whether YAP1 or TAZ was regulated in this setting by
examining their expression in bone tissue and in calvarial osteo-
blasts from SOX2 CKO animals. We carried out quantitative
RT-PCR (qRT-PCR) using messenger RNA (mRNA) extracted
from femurs and calvaria of mice with an Osterix-CRE condi-
tional SOX2 knockout in homozygous and heterozygous config-
urations. YAP1 expression levels were reduced to 20%–30% of
WT in SOX2CKO femurs and calvaria, whereas the expression of
TAZ was not significantly changed (Figures 2A and 2B). Primary
osteoblast cultures derived from SOX2 CKO mice also showed
decreased YAP1 protein expression, whereas TAZ expression
was unaffected (Figure 2C). The reduced YAP1 expression was
evident despite the mosaic excision of SOX2 in these mice
(Basu-Roy et al., 2010; Seo et al., 2011). To determine whether
the decreased YAP1 expression in SOX2 knockout cells affected
the expression of known YAP1 target genes, we examined the
expression of a YAP1 target gene set (Zhang et al., 2009) in the
SOX2 floxed cells 24, 48, and 72 hr after CRE virus infection.
Several YAP1 target genes were significantly downregulated
upon SOX2 excision, whereas little change occurred in control
GFP-virus-infected cells (Figures 2D and S2A). Some of these
genes that are known to be important in osteoblast biology
were validated by qRT-PCR in SOX2 knockout and YAP1
knockdown cells (Figure S2B). Their downregulation con-
firmed that these are bona fide YAP1 targets in osteoprogenitor
cells.
Figure 1. YAP1 Is a Target of SOX2
(A and B) SOX2 binds to the Yap1 genomic region
in osteoprogenitor cells.
(A) SOX2 CHIP-seq shows two peaks of SOX2-
bound genomic sequences around exons I and II
of Yap1 in control and SOX2-overexpressing cells.
(B) CHiP-PCR with primers around exon I in SOX2-
overexpressing (OB1-SOX2) or control OB1 cells.
A schematic of primers and SOX2-binding sites
(red bars) in the first peak is shown. TSS, tran-
scription start site.
(C) YAP1 and TAZ mRNA expression analysis in
SOX2-depleted osteoprogenitors. SOX2F/F cells
were transduced with CRE- or GFP lentivirus, and
YAP1 and TAZ expression was analyzed by qRT-
PCR. Gene-expression values in CRE-infected
cells are normalized to that of GFP-lentivirus-
infected cells.
(D) YAP1 expression by western analysis in
SOX2F/F osteoprogenitors infected with SOX2
lentivirus. See also Figure S1.
(E and F) SOX2 induces expression of a Yap1
reporter.
(E) 293T cells were infected with SOX2 or control
() lentivirus and transfected with a Yap1 243-bp-
region-driven Venus fluorescent reporter.
(F) Activity of the Yap1-luciferase reporter.
C3H10T1/2 cells were infected with lentiviral SOX2
or control vector and then transfected with
Fgf4 minimal promoter reporter or Fgf4 minimal
promoter containing the Yap1 243 bp region.
Luciferase activity was normalized to Renilla.
*p < 0.05; error bars represent the average + SD.YAP1 Rescues the Proliferation Defect Caused by SOX2
Depletion
Depletion of SOX2 leads to growth arrest and senescence in
primary osteoblasts cultures and osteoprogenitor cell lines.
This effect can be clearly measured in a colony-formation assay
of SOX2-floxed osteoprogenitor cells infectedwith aGFP or CRE
virus (Basu-Roy et al., 2010). Since YAP1 has a role in self-
renewal of ESCs (Lian et al., 2010) and is regulated by SOX2,
we tested whether YAP1 is able to replace SOX2 function in
the self-renewal of osteoprogenitors and rescue the defect in
proliferation caused by SOX2 deletion. SOX2F/F cells were trans-
duced with SOX2 or YAP1 transgenes using lentivirus vectors.
The cells were then infected with CRE-expressing lentivirus to
excise SOX2, or with a GFP control lentivirus, and the colony-
forming ability of GFP- or CRE-expressing cells was measured
as previously described (Basu-Roy et al., 2010). In line with ourCell Reports 3, 2075–208previously published data (Basu-Roy
et al., 2010), CRE-mediated deletion in
Sox2F/F cells caused a dramatic loss of
colony-forming ability (Figure 2E), with
the surviving fraction representing cells
that had escaped CRE-virus infection.
As expected, expression of a SOX2 trans-
gene rescued the defect in colony-form-
ing ability in the SOX2-deleted cells.
Rescue was equally efficient in the pres-ence of a YAP1 transgene introduced into Sox2F/F cells. Western
analysis confirmed that YAP1 protein expression was reduced in
the SOX2-deleted cells and restored in the YAP1 transgene-
expressing cells (Figure 2E). These results indicate that YAP1
expression maintained by SOX2 is important for self-renewal of
osteoprogenitors.
To determine the specificity of YAP1 for rescuing the prolifer-
ation defect caused by SOX2 inactivation, we tested another
SOX2 target gene, c-Myc, which was also identified as a direct
target in the SOX2 ChIP-seq analysis and is also downregu-
lated upon SOX2 excision. A ChIP-PCR assay confirmed that
SOX2 binding to the c-Myc promoter region was enhanced,
but c-Myc overexpression failed to restore the defect of colony
formation in SOX2 null cells (data not shown). Thus, although
c-Myc is also a SOX2 target gene that drives proliferation, in
contrast to YAP1, c-Myc expression is not sufficient to7, June 27, 2013 ª2013 The Authors 2077
Figure 2. YAP1 Is Regulated by SOX2 In Vivo and In Vitro, and Can Compensate for SOX2 Depletion in Osteoprogenitors
(A and B) SOX2, TAZ, and YAP1 gene expression in vivo. qRT-PCR analysis of mRNA directly from (A) femurs of 8-week-old mice and (B) calvaria of P1 pups. All
values are normalized to 18S rRNA and expressed as fold change compared with WT. SOX2 +/: heterozygote; SOX2 CKO: SOX2 conditional knockout (CKO1
and CKO2 are two independent isolations). *p < 0.05. Error barsrepresent SD.
(C) Western analysis of SOX2, TAZ, and YAP1 expression in WT and SOX2 CKO osteoprogenitors.
(D) Heatmap of YAP1 target genes in SOX2-depleted cells. SOX2F/F osteoprogenitors were infected with a GFP or CRE lentivirus virus for 24, 48, and 72 hr.
Expression of the YAP1 target gene set (Zhang et al., 2009) is shown. Venn diagram shows overlap between a subset of genes that were significantly changed by
SOX2 knockdown and the YAP1 target gene set. See also Figures S2A and S2B.
(E) Rescue of the colony-forming ability of SOX2-deleted osteoprogenitors by YAP1. A colony assaywas conducted on SOX2-deleted cells expressing transgenic
SOX2 or YAP1. SOX2F/F cells were infected with a control (vector), SOX2, or YAP1 lentivirus followed by SOX2 deletion with CRE lentivirus, and assayed for
colony-forming ability. Western analysis of YAP1 is shown. Each experiment was repeated at least twice. Results from a representative experiment are shown.
*p < 0.05; error bars represent the average + SD.
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Figure 3. SOX2 Deletion in Primary BM-
MSCs Leads to Decreased YAP1 and
Reduced Colony Formation that Can Be
Rescued by YAP1
(A) Western analysis of SOX2, YAP1, and TAZ in
BM-MSCs isolated from WT or SOX2 CKO mice.
(B) Colony assay (in fibroblast colony-forming units
[cfu-f]) of BM-MSCs isolated from 4-week-old
SOX2EGFP/+, osterix-CRE (heterozygous) or
SOX2EGFP/F, osterix-CRE (SOX2 CKO) mice; 105
cells were plated in triplicate and analyzed as in
Figure 2E. *p < 0.05.
(C) Western analysis and colony assay of SOX2 F/+
or SOX2F/F BM-MSCs following in vitro CRE-
mediated deletion of endogenous SOX2. Primary
BM-MSCs were isolated from 4-week-old mice
infected with control (GFP) or SOX2-deleting (CRE)
virus. *p < 0.05.
(D) Rescue of the colony-forming ability of SOX2-
deleted BM-MSCs by YAP1. Western analysis and
colony assay were conducted on SOX2 F/ BM-
MSCs overexpressing YAP1 and depleted of
endogenous SOX2 by CRE lentivirus infection.
*p < 0.05; error bars represent the average + SD.
See also Figure S3.compensate for SOX2 function in self-renewal of osteopro-
genitors. Interestingly, TAZ (WWTR1), which is not a SOX2
direct target, partially compensated for SOX2 deficiency
when overexpressed, although it did so much less efficiently
than YAP1 (Figures S2C and S2D), probably due to its high
homology to YAP1.
SOX2 and YAP1 Are Expressed in BM and Fat
Since SOX2 is required tomaintain self-renewal and the undiffer-
entiated state in the osteoblastic lineage and MSCs (Basu-Roy
et al., 2010; Park et al., 2012b), we determined the expression
of SOX2 and YAP1 in bone sections, including BM. BM forms
a complex stem cell niche that contains cells of the mesen-
chymal and hematopoietic lineages (Me´ndez-Ferrer et al.,
2010). Immunohistochemistry showed that SOX2 and YAP1
are both expressed in adipocytes adjacent to the femur and tibia
(Figure S4A), as well as in adipocytes lining the cortical bone at
the bone collar (not shown). SOX2 and YAP1 are undetectable
in cortical bone, but positive cells are detected in trabecular
bone adjacent to the growth plate, surrounding the areas of
bone formation, consistent with the position of immature osteo-
progenitor cells (see Figure S4A, inset). Western analysis also
confirmed expression of both SOX2 and YAP1 in inguinal fat
and compact bone tissue (see Figure S4B). Thus, SOX2 and
YAP1 are expressed in immature osteoprogenitor cells and
adipocytes.
SOX2 Regulates YAP1 to Maintain Self-Renewal in
MSCs
YAP1 expression is induced in MSCs and C3H10T1/2 cells that
overexpress SOX2 (Figure S1). To determine whether YAP1Cexpression was dependent on endogenous SOX2 in MSCs, we
isolated MSCs from WT or SOX2 CKO mice and examined the
expression of SOX2 and YAP1. Somewhat surprisingly, since
the OSX-CRE transgene was not expected to be expressed in
MSCs, we found that SOX2 protein was substantially reduced
in the SOX2 CKO MSCs and, as in the osteoprogenitors, the
expression of YAP1 was reduced, whereas TAZ expression
was low and not significantly altered compared with control
MSCs (Figure 3A). Consistent with a role for SOX2 in MSC
self-renewal, primary MSCs isolated from the SOX2 CKO mice
produced fewer colonies than those obtained from heterozygous
littermate mice (Figure 3B). A similar reduction in colony
formation was seen upon CRE infection of MSCs from SOX2F/F
mice (Figure 3C). YAP1 overexpression was able to efficiently
rescue this defect in self-renewal in SOX2-depleted MSCs
(Figure 3D). As in the osteoprogenitors, although we did not
observe any regulation of TAZ by SOX2, TAZ overexpression
was able to partially rescue self-renewal in SOX2-depleted
MSCs (Figure S3A).
These experiments indicate that SOX2 is required for
self-renewal and maintenance of MSCs, and that YAP1 is a
downstream effector of SOX2 in maintaining these stem cells.
SOX2 Is a Lineage-Fate Determinant in MSCs
SOX2 maintains self-renewal in the osteoblast lineage, where its
constitutive expression inhibits osteogenic differentiation by
maintaining a stemness gene-expression signature and through
the downregulation of Wnt/b-catenin signaling (Seo et al., 2011).
Wnt signaling is a key switch that drives osteogenesis and
inhibits adipogenesis (Kang et al., 2007; Prestwich andMacdou-
gald, 2007). We therefore investigated whether SOX2 affects theell Reports 3, 2075–2087, June 27, 2013 ª2013 The Authors 2079
Figure 4. SOX2 Inhibits Osteogenesis and
Enhances Adipogenesis
(A and B) Osteogenic differentiation in SOX2-
overexpressing BM-MSCs (A) or C3H10T1/2 cells
(B). Cells were infected with SOX2 lentivirus and
maintained in osteogenic conditions for the indi-
cated days and stained for alkaline phosphatase
(purple color). SOX2 expression by western anal-
ysis is shown.
(C) Osteogenic differentiation in C3H10T1/2 cells
expressing scrambled (control) or SOX2 shRNA
(shSOX2).
(D) Adipogenic differentiation in SOX2-over-
expressing BM-MSCs. Cells were infected as in
(A) and maintained in adipogenic conditions for
10 days and stained with Oil Red O. Lower panel:
quantification of Oil Red O-positive adipocytes.
(E) PPARg expression and adipogenic differentia-
tion in SOX2-overexpressing or SOX2 knockdown
C3H10T1/2 cells. Cells were infected with SOX2
lentivirus (SOX2) or SOX2 shRNA (shSOX2).
PPARg expression by western analysis is shown.
Lower panel: Oil Red staining.
(F) Adipogenic differentiation in Sox2EGFP/+ BM-
MSCs. Primary cells isolated from Sox2EGFP/+
mice were maintained in adipogenic differentiation
medium. SOX2 expression was evaluated after
10 days by fluorescence microscopy and cells
stained with Oil Red O. Magnification: 103
and 203.
*p < 0.05; error bars represent the average + SD.
See also Figure S4.choice of MSCs to differentiate into an osteo- or adipogenic line-
age. Lentiviral-mediated SOX2 overexpression in primary MSCs
or C3H10T1/2 led to inhibition of osteogenesis (Figures 4A and
4B). Consistent with this observation, SOX2 mRNA expression
was reduced during osteogenesis (Figure S4C) and SOX2
knockdown enhanced this process (Figure 4C). Thus, in line
with its role in inhibiting differentiation inmoremature osteogenic
cells, SOX2 also prevents osteogenesis in MSCs. Constitutive
SOX2 expression enhanced adipogenic differentiation in the
same cells, as measured by an increase in adipocytes staining
with Oil Red O (Figure 4D). Adipogenesis was substantially
increased in SOX2-expressing cells compared with control
vector-expressing cells in both MSCs and C3H10T1/2, and
strongly decreased in cells expressing SOX2 small hairpin RNA
(shRNA). We also confirmed that PPARg, the master regular of
adipogenesis, was induced in SOX2-overexpressing cells and
reduced in SOX2-depleted cells (Figure 4E). These results indi-
cate that SOX2 is able to determineMSC lineage fate by favoring
the adipogenic state over the osteogenic one. To verify this
further, we isolated MSCs from mice in which one of the SOX2
alleles is replaced by an EGFP cassette, driven by the endoge-
nous SOX2 regulatory elements (Ellis et al., 2004), and the other
SOX2 allele is WT (Sox2EGFP/+). Initially, MSC cultures contained
very few (<0.5%) cells expressing detectable EGFP (not shown).
However, upon induction of adipogenic differentiation, the
number of GFP-positive cells increased and eventually all cells
that were positive for Oil Red staining were also clearly express-
ing GFP (Figure 4F). Thus, adipogenic differentiation appears to2080 Cell Reports 3, 2075–2087, June 27, 2013 ª2013 The Authorsselect for cells expressing sustained levels of SOX2 or to induce
SOX2 expression.
YAP1 Expression or Inactivation of Hippo Signaling
Inhibits Osteogenesis and Regulates Adipogenesis
Since YAP1 expression is regulated by SOX2, we sought to
determine whether YAP1 can affect osteogenic or adipogenic
MSC differentiation. Consistent with it being a SOX2 transcrip-
tional target, YAP1 mRNA is decreased during osteogenesis
but increased during adipogenesis (Figure S5A). However,
YAP1 protein expression was maintained in osteogenesis
compared with undifferentiated cells, but was significantly lower
in cells undergoing adipogenesis (Figures 5A and S6). We spec-
ulate that posttranscriptional regulatory mechanisms control
YAP1 protein levels during osteogenic or adipogenic differentia-
tion (Figures 5A and S6). To determine whether YAP1 regulates
osteogenic or adipogenic differentiation of MSCs, we utilized
retroviral vectors bearing WT YAP1 or a constitutively active
mutant YAP1(2SA) in which serines 127 and 381 were mutated
to alanine, or shRNAs for MST1 and MST2, the negative regula-
tors of YAP1 in the Hippo pathway. We found that knockdown of
MST1/2 led to increased levels of YAP1 protein (Figures 5D and
S5B) and a higher proportion of cells exhibited YAP1 nuclear
staining (Figure S5C).
Expression of WT YAP1 or YAP1(2SA), or depletion of MST1
and MST2 (shMST1/2) inhibited osteogenic differentiation in
primary MSCs (Figure 5B). However, although SOX2 overex-
pression in MSCs favors adipogenesis, we found that
Figure 5. YAP1 Overexpression Inhibits Osteogenesis and Adipogenesis in MSCs
(A) Western analysis of YAP1, RUNX2, and PPARg in BM-MSCs undergoing osteogenic or adipogenic differentiation for 3 days. See also Figure S5A.
(B) Osteogenic differentiation of primary BM-MSCs infected with control (vector), YAP1, or YAP1(2SA) virus, or with shRNA lentivirus against MST1 and MST2
(shMST1/2).
(C) Adipogenic differentiation of primary BM-MSCs and C3H10T1/2 cells infected as in (B).
(D) Western analysis of YAP1 expression during adipogenesis in C3H10T1/2 cells as in (C). See also Figures S5B and S5C.
(E) Quantification of adipogenesis by Oil Red staining in C3H10T1/2 cells infected as in (C) at 10 days.
(F) qRT-PCR analysis of differentiationmarkers. mRNAwas extracted fromC3H10T1/2 cells expressing the indicated constructs. All values are expressed as fold
change and normalized to 18S rRNA compared with control.
*p < 0.05; error bars represent the average + SD. See also Figure S6.expression of WT YAP1 or mutant YAP1(2SA), or knockdown of
MST1/2 inhibited adipogenic differentiation of MSCs and of
C310T1/2 cells (Figure 5C). As in the MSCs, adipogenic differ-
entiation of C3H10T1/2 cells led to a decrease of endogenous
YAP1 protein (Figure 5D). In contrast, endogenous YAP1 per-
sisted and adipogenesis was inhibited in MST1/2-depleted
cells, although not as strongly as in WT YAP1 or mutant
YAP1(2SA)-overexpressing cells (Figures 5D and 5E). The
inhibition of adipogenesis correlated with increased nuclear
localization of YAP1 in YAP1-, YAP1(2SA)-, and MST1/2
shRNA-expressing cells (Figure S5C). Expression of the differ-
entiation-related genes osteopontin, osteocalcin, and PPARg
was also reduced by overexpression of YAP1 and YAP1(2SA)
(Figure 5F). Thus, although SOX2 expression in MSCs favors
adipogenesis, and YAP1 mRNA is induced by SOX2, YAP1 pro-Ctein is actually downregulated in this process and its overex-
pression inhibits adipogenesis.
We reasoned that only a narrow range of YAP1 expression
could be compatible with adipogenesis. To test this hypothesis,
we sought to determine how different degrees of YAP1 expres-
sion influence adipogenesis.
To that end, YAP1was depleted or transgenic YAP1was over-
expressed or re-expressed in cells depleted of YAP1 (Figure 6A).
Knockdown of YAP1 expression by shRNA led to a significant
reduction of adipocyte formation, showing that YAP1 is required
for adipogenesis (Figure 6B). However, overexpression of YAP1
at much higher levels (5-fold) also inhibited adipogenesis (Fig-
ure 6B). Reflecting this, higher levels of PPARgwere induced un-
der basal conditions, whereas overexpression of YAP1 or knock-
down of YAP1 drastically reduced PPARg induction (Figure 6C).ell Reports 3, 2075–2087, June 27, 2013 ª2013 The Authors 2081
Figure 6. Moderate YAP1 Expression En-
ables Adipogenesis and PPARg Expression
(A) Western analysis of YAP1 expression. C3H10T1/
2 cells were infected with YAP1, YAP1shRNA
(shYAP1), or shYAP1 and YAP1 (shYAP1 +YAP1
rescue) lentivirus.
(B and D) Adipogenesis and osteogenesis in cells
expressing different levels of YAP1. Cells were
transduced as in (A), incubated in adipogenic (B) or
osteogenic (D) media for 10 days, and stained as in
Figures 4A and 4B.
(C) PPARg expression is regulated by YAP1 during
adipogenesis. Western analysis of C3H10T1/2 cells
expressing YAP1 or shYAP1 during adipogenic
differentiation for the indicated days is shown.
(E) YAP1 is a key downstream target of SOX2 in
osteogenesis. Osteogenesis in C3H10T1/2 cells
expressing control or SOX2 lentivirus that were
infectedwith either control (scrambled) or shYAP1 is
shown.
(F) Adipogenesis assay of cells infected as in (E).
(G) Western analysis of cells used in (E) and (F).
See also Figure S6.In YAP1 knockdown cells, moderate re-expression of transgenic
YAP1 rescued the YAP1 deficiency and enhanced adipogenesis
(Figure 6B). Thus, induction of adipogenesis requires moderate
levels of YAP1 expression. In sharp contrast to the effect of
YAP1 expression levels on adipogenesis, cells with knockdown
of YAP1 are enhanced in their ability to undergo osteogenic dif-
ferentiation, whereas YAP1 overexpression prevents this pro-
cess (Figure 6D).
To determine whether YAP1 mediates the effects of SOX2 in
MSC fate determination, we examined the effect of YAP1 deple-
tion on lineage fate in SOX2-overexpressing cells (Figure 6G).
The inhibitory effect of SOX2 overexpression on osteogenic dif-
ferentiation was blocked in cells expressing shYAP1 (Figure 6E).
YAP1 knockdown did not significantly alter adipogenesis in
SOX2-overexpressing cells (Figure 6F). Together, these results
suggest that YAP1 is induced by SOX2, and that this SOX2-
YAP1 axis is important for its inhibitory effect on osteogenic dif-
ferentiation but is not essential for adipogenesis when SOX2 is
overexpressed. YAP1 expression must be restrained, but not2082 Cell Reports 3, 2075–2087, June 27, 2013 ª2013 The Authorsabolished, for adipogenic differentiation
of MSCs (see Discussion). Thus, we pro-
pose that YAP1 acts as a rheostat to regu-
late the fate determination of MSCs.
YAP1 Regulates Wnt/b-Catenin
Signaling by Inducing Dkk1 and
Binding to b-Catenin
SOX2 inhibits Wnt/b-catenin signaling
through multiple mechanisms, including
binding to b-catenin and inducing negative
regulators of Wnt signaling such as APC
and GSK3b (Ambrosetti et al., 2008;
Holmes et al., 2011; Mansukhani et al.,
2005; Park et al., 2012b; Seo et al., 2011).
Extensive crosstalk between Hipposignaling and Wnt signaling has been observed in different sys-
tems, and both YAP1 and TAZ have been reported to interact
with b-catenin (Azzolin et al., 2012; Heallen et al., 2011; Hergo-
vich and Hemmings, 2010; Imajo et al., 2012; Konsavage et al.,
2012; Rosenbluh et al., 2012). We examined whether YAP1
affects Wnt/b-catenin signaling in our system. C3H10T1/2 cells
stably expressing the Wnt reporter pTOP-luciferase were trans-
duced with control vector or YAP1-expressing lentivirus and
then treated with CHIR99021, a potent GSK3b-specific inhibitor
that leads to Wnt/b-catenin reporter activation. Luciferase
reporter activity in untreated cells was low, reflecting a basal
state of Wnt signaling. The increased luciferase activity caused
by CHIR99021 treatment was reduced by YAP1 expression (Fig-
ure 7A) suggesting that YAP1 inhibits canonical Wnt signaling.
We tested whether YAP1 interacts with b-catenin in C3H10T1/
2 cells, and found that WT YAP1, but not mutant YAP1(2SA), im-
munoprecipitates with b-catenin (Figure 7B), suggesting that
YAP1 may interfere with b-catenin-dependent Wnt signaling. In
line with this hypothesis, we found that chromatin-bound
Figure 7. YAP1 Inhibits Wnt/b-Catenin
Signaling by Binding b-Catenin and
Inducing Dkk1
(A) Luciferase assay of Wnt reporter in YAP1-
expressing cells. C3H10T1/2 pTOP-FLASH cells
were infected with control or YAP1 lentivirus and
treated with 4.5 mM of CHIR 99021 for 10 hr. Firefly
luciferase activity (Wnt response) was normalized
to Renilla.
(B) Immunoprecipitation of b-catenin. C3H10T1/2
cells were infected with flag-YAP1 or flag-
YAP1(2SA) virus and whole-cell lysates were
immunoprecipitated (IP) with Flag antibody.
Immune complexes and whole-cell lysates were
immunoblotted (IB) as indicated.
(C) Dkk1 mRNA expression analysis by qRT-
PCR. C3H10T1/2 cells were infected with the
indicated lentiviral vectors and Dkk1 expression
was analyzed.
(D) ChIP assay for the YAP1/TEAD-binding Dkk1
upstream region. C3H10T1/2 cells were infected
with control, flag-YAP1, or flag-YAP1(2SA) and
ChIP was performed with Flag antibody. Dkk1
genomic fragments were amplified by PCR with
specific primers to sequences flanking YAP1/
TEAD binding sites (red bars).
(E) Luciferase-reporter assay of Dkk1-promoter
(Dkk1-pro) or Dkk1-pro with mutations in TEAD-
binding sites (red nucleotides; Mut1/2). A 730 bp
region from 1,450 to 720 upstream of the Dkk1
TSS (Dkk1-pro) was subcloned into minimal
FGF4 luciferase reporter and transfected into
C3H10T1/2 cells expressing YAP1 or control vec-
tors. Luciferase activity was normalized to Renilla.
(F) Osteogenic differentiation. C3H10T1/2 cells
were infected by the indicated viral vectors and an
osteogenesis assay was performed. Western blot
of cells expressing shDkk1 shows that the YAP1
protein level is unaffected.
(G) YAP1 inhibits Wnt during osteogenesis.
C3H10T1/2-pTOP-FLASH cells were infected with
control () or YAP1(2SA) and subjected to osteo-
genic differentiation for the indicated days. Firefly
luciferase activity was normalized to Renilla.
*p < 0.05; error bars represent the average + SD.
See also Figure S7.b-catenin was decreased in YAP1-overexpressing cells and
increased in shYAP1 cells (Figure S7B). In the same cells, we
tested the effect of Wnt3A stimulation on the expression of
several genes that we previously identified as Wnt targets in
the osteogenic lineage (Ambrosetti et al., 2008). Wnt3A signifi-
cantly increases the expression of these genes, and this effectCell Reports 3, 2075–208was enhanced in shYAP1-expressing
cells and reduced in cells overexpressing
YAP1 (Figure S7C). Thus, YAP1 inhibits
induction of Wnt target genes.
An analysis to identify potential YAP1
targets (D.L., unpublished data) revealed
that Dkk1, the inhibitory ligand of the
Wnt pathway, has an upstream promoter
region containing YAP1/TEAD consensussites. qRT-PCR confirmed that Dkk1 mRNA expression was
increased by YAP1 or YAP1(2SA) mutant, but not by a TEAD-
binding mutant, YAP1(S94A) (Figure 7C). ChIP analysis
confirmed the enhanced binding of flag-tagged YAP1 and
YAP1(2SA) to the Dkk1 upstream region (Figure 7D). Accord-
ingly, a reporter assay showed that YAP1 enhanced the7, June 27, 2013 ª2013 The Authors 2083
expression of luciferase from a Dkk1 promoter-reporter
plasmid, including two putative YAP1/TEAD-binding consensus
sequences, and mutations in these YAP1/TEAD-binding sites
led to the reduction of its promoter activity (Figure 7E). These
data indicate that YAP1 transcriptionally enhances the expres-
sion of Dkk1.
Dkk1 is a potent inhibitor of Wnt signaling and its expression
decreases during osteogenic differentiation (Figure S7A). This
led us to test whether Dkk1 knockdown could overcome the
inhibition of osteogenic differentiation in YAP1-overexpressing
MSCs. Primary MSCs constitutively expressing YAP1 were
impaired in osteogenic differentiation, but Dkk1 knockdown in
these cells was able to overcome the block in osteogenesis (Fig-
ure 7F). Furthermore, the expression of aWnt-luciferase reporter
that was induced during osteogenic differentiation was
repressed in cells expressing YAP1(2SA) (Figure 7G). These
results suggest that together with its binding to b-catenin, the
ability of YAP1 to induce Dkk1-mediated inhibition of Wnt
signaling plays a significant role in the inhibition of osteogenic
differentiation.
DISCUSSION
In this report, we show that SOX2 regulates the osteo-adipo
lineage fate in MSCs and that it does so, at least in part, by regu-
lating the expression of YAP1, a transcriptional effector that is
restrained by the Hippo pathway. SOX2 maintains stemness
and inhibits osteogenic differentiation in adult stem cells,
whether MSCs or osteoprogenitors, but also is required for
adipogenic differentiation. SOX2 directly targets YAP1, and the
SOX2-induced YAP1 maintains stemness and inhibits osteo-
genesis. YAP1 also cooperates with the antagonistic effect of
SOX2 on Wnt signaling by binding b-catenin and inducing the
expression of the Wnt inhibitor, Dkk1. Depletion of YAP1 dere-
presses Wnt signaling and enhances osteogenesis. By damp-
ening Wnt signaling, which promotes osteogenesis and inhibits
adipogenesis, both SOX2 and YAP1 tip the balance of SOX2-
expressing cells toward stemness and allow adipogenic
differentiation. Thus, alternate fate choices of osteogenesis or
adipogenesis are determined by the levels of SOX2 and YAP1
as well as by the extent of YAP1 phosphorylation and derepres-
sion of Wnt signaling.
YAP1 Is a Target of SOX2
YAP1 and TAZ are cofactors for the transcription factors of the
TEAD and RUNX family, and are regulated by the conserved
Hippo signaling pathway that controls organ size and regener-
ation (Dong et al., 2007; Halder and Johnson, 2011; Zhao
et al., 2010). The Hippo pathway is now being recognized as
an integrator of mechanical and cellular-contact-dependent
sensory signals with intracellular components that regulate
cell-fate decisions (Schroeder and Halder, 2012). The intracel-
lular Hippo pathway consists of a phosphorylation relay by the
STE kinases MST1 and MST2, and the NDR kinases LATS1
and LATS2, which phosphorylate YAP1 and TAZ (Zhao et al.,
2011), thereby leading to their cytoplasmic retention (Zhao
et al., 2009). Thus, active Hippo signals inhibit the transcrip-
tional activity of YAP1 and TAZ, and SOX2 probably counter-2084 Cell Reports 3, 2075–2087, June 27, 2013 ª2013 The Authorsacts the repressive effect of Hippo signaling on YAP1 tran-
scriptional activity.
We previously reported that loss of self-renewal due to SOX2
deletion in osteoprogenitors can be rescued by the Polycomb
factor BMI-1 (Seo et al., 2011). Interestingly, BMI-1-rescued cells
have low levels of YAP1, whereas expression of BMI-1 is
enhanced in YAP1-rescued cells (not shown), suggesting a
SOX2/ YAP1/ BMI-1 axis in these cells.
Interestingly, TAZ can also partially rescue the defect in self-
renewal due to SOX2 depletion, although it is not regulated by
SOX2.Given their similar function, this is not surprising.However,
endogenous TAZ is not sufficient to compensate for SOX2 and
YAP1 loss, and rescue by TAZ is less efficient than rescue by
YAP, probably because TAZ andYAP have only partially overlap-
ping gene targets (Zhang et al., 2009). The self-renewal function
of SOX2 cannot be compensated for by c-MYC, another propro-
liferative SOX2 target. This finding is in contrast to work by Park
et al. (2012b), who reported that SOX2 depletion in human
MSCs by shRNA could be rescued by c-MYC. This discrepancy
could arise from the fact that CRE-mediated DNA excision in our
system results in complete SOX2 ablation, which may not be
compensated for by c-MYC. Thus, c-MYC may cooperate with
SOX2 in promoting self-renewal, but cannot compensate for
complete loss of SOX2 function.
SOX2 and YAP1 Are Determinants of the Adipo-Osteo
Lineage
Several lines of evidence suggest a reciprocal relationship
between the adipocytic and osteoblastic lineages (Kang et al.,
2007; Takada et al., 2009), and our findings indicate that SOX2
and YAP1 regulate this lineage fate choice in MSCs. As with
SOX2, YAP1 overexpression blocks osteogenesis, and YAP1 is
a key downstream mediator of SOX2 function in this process
because the block does not occur if YAP1 is depleted in
SOX2-overexpressing cells. Alternately, SOX2 overexpression
strongly favors adipogenesis, and we found that depletion of
either SOX2 or YAP1 prevents adipogenic differentiation and
induction of PPARg. However, overexpression of SOX2 com-
pensates for depletion of YAP1 and allows adipogenesis to pro-
ceed, suggesting that SOX2 and YAP1 could have overlapping
functions in this process. Although the overexpression studies
suggest that the SOX2-YAP1 axis is not a key mediator of
SOX2 function in promoting adipogenesis, we cannot exclude
the possibility that basal SOX2 induction of YAP1 transcription
is necessary to maintain the discrete levels of YAP1 that are
conducive to adipogenesis.
Both YAP1 knockdown by shRNA and YAP1 overexpression
impaired adipogenesis, which can readily proceed in cells with
moderate levels of YAP1 expression. This finding appears to
be somewhat paradoxical and is not reflected in the levels of
YAP1 mRNA during adipogenesis. Indeed, although SOX2
mRNA and protein are both induced during adipogenesis,
YAP1 mRNA levels increase during adipogenesis, in line with
its being a SOX2 target, but the protein is decreased. Thus, it
is likely that additional posttranscriptional mechanisms, such
as activation of the proadipogenic effect of components of the
Hippo pathway (Park et al., 2012a), may restrain YAP1 protein
levels during adipogenesis, which appears to be exquisitely
sensitive to the concentration of YAP1. Elevated YAP1 strongly
induces proliferation in MSCs (U.B.R. and A.M., unpublished
data) that could counteract the proadipogenic effect of MST
and Sav1 components of the Hippo pathway (Park et al.,
2012a). In line with this, we find that YAP1 overexpression
inhibits expression of PPARg, which is reduced upon YAP1
depletion. YAP1 depletion would lead to increasedWnt signaling
that inhibits PPARg and adipogenesis. Thus, SOX2 and YAP1
function in progenitors upstream of PPARg to regulate cell-fate
choice in MSCs.
In contrast to YAP1, TAZ has been described as having
a pro-osteogenic and antiadipogenic function. TAZ binds to
and promotes RUNX2 activity while blocking PPARg function,
providing an explanation for its effects. Our data indicate that
YAP1 actually inhibits osteogenesis. Indeed, YAP1 was reported
to inhibit RUNX2 function by sequestering its transcriptional
activity (Zaidi et al., 2004), and unlike TAZ, YAP1 did not bind
PPARg (Hong et al., 2005). FGFs are also known to inhibit osteo-
genesis, and have been reported to be proadipogenic factors
(Hutley et al., 2011; Mansukhani et al., 2000). Given that we orig-
inally found SOX2 to be an FGF-induced gene in osteoprogenitor
cells, we speculate that the FGFs’ effects on fat tissue may also
be mediated by SOX2.
Crosstalk among SOX2, Hippo, and Wnt Signaling in the
Mesenchymal Lineage
We show that, like SOX2, YAP1 blocks osteogenic differentiation
and antagonizes theWnt signaling pathway by binding b-catenin
and inducing the Wnt negative regulator Dkk1. SOX2 can also
directly induce Dkk1 expression via a region in the Dkk1 pro-
moter that lies upstream of the YAP1-inducible region that we
identified (Park et al., 2012b), suggesting that Dkk1 may be syn-
ergistically regulated by SOX2 and YAP1. Wnt signaling is the
best-known regulatory ‘‘switch’’ for the osteo-adipo lineage
fate choice (Takada et al., 2009). Several genetic and biochem-
ical studies have established that Wnts drive osteogenesis at
the expense of adipogenesis (Kang et al., 2007; Song et al.,
2012). We previously showed that SOX2 represses the Wnt
pathway (Seo et al., 2011). SOX2 can bind b-catenin and also
directly induces GSK3b and APC, negative regulators of Wnt
signaling. Several Wnt target genes are activated in osteoblast
lineage cells in which SOX2 has been deleted (Basu-Roy et al.,
2011). Thus, both SOX2 and YAP1 are negative regulators of
the Wnt pathway and thereby influence fate choice in the
osteo-adipo lineage. Several points of crosstalk between the
Hippo and Wnt pathways in both the cytoplasm and nucleus
were recently reported (Heallen et al., 2011; Imajo et al., 2012;
Varelas et al., 2010). We found that YAP1 was immunoprecipi-
tated with b-catenin, but YAP1(2SA), the transcriptionally active
unphosphorylated mutant, was not. This is in line with previous
findings that Hippo pathway activation leading to phosphory-
lated YAP1 prevents Wnt signaling (Imajo et al., 2012). YAP1
not only blocks Wnt signaling and hence osteogenic differ-
entiation, but interestingly is also regulated by mechanotrans-
ductive properties that influence cell fate (Dupont et al., 2011).
In conclusion, we have described a Hippo-independent regu-
lation of YAP1 by SOX2 that influences self-renewal and lineage-
fate determination in the osteo-adipo lineage.CEXPERIMENTAL PROCEDURES
Cell Culture
The immortalized osteoprogenitor cells, OB1, Sox2F/F, and Sox2F/, have
been previously described (Basu-Roy et al., 2010; Mansukhani et al., 2000).
C3H10T1/2 was obtained from ATCC. C3H10T1/2-TOP cells (Seo et al.,
2011) were grown in 400 mg/ml G418. Primary BM-MSCs from WT, Sox2F/F
or Sox2F/F Osx-CRE, and SOX2EGFP/+ (Ellis et al., 2004) mice were isolated
from 4- to 6-week-old femurs. MSC isolation was carried out according to
the protocol of the media manufacturer (StemCell Technologies) and grown
in MesenCult (No. 05511). BM-MSC or C3H10T1/2 cells were infected with
YAP1 or YAP1 (2SA) retrovirus and selected with 2 mg/ml puromycin. To obtain
MST1/2-depleted cells, cells were cotransduced with shRNA against MST1
andMST2 in a lentiviral vector in vitro, and selected with 500 mg/ml of hygrom-
ycin and 2 mg/ml of puromycin.ChIP-Seq and Data analysis
For SOX2-bound regions in osteoprogenitors, chromatin for immunoprecipita-
tion was prepared as previously described (Seo et al., 2011). See Extended
Experimental Procedures for further details.Differentiation Assay
In vitro osteogenic and adipogenic differentiation was carried out as previously
described (Basu-Roy et al., 2011).Colony Assay
Complementation of SOX2 deletion in the SOX2F/F and SOX2F/ osteoproge-
nitor cell lines was carried out by colony-formation assay as described previ-
ously (Basu-Roy et al., 2010; Seo et al., 2011).Gene-Expression Analysis by Real-Time qRT-PCR and Western
Blotting
mRNA was prepared with the use of Trizol Reagent (Invitrogen). Real-time
qRT-PCR analysis was carried out as previously described (Basu-Roy
et al., 2010). For the specific primers and antibodies used, see Extended
Experimental Procedures.SUPPLEMENTAL INFORMATION
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